Akorn's drug pipeline 'held hostage' with FDA warning letter

Akorn disclosed Wednesday that it had received a warning letter from the Food and Drug Administration, citing numerous violations at the company’s Decatur, Illinois manufacturing facility and calling past responses to agency critiques inadequate.